Nadja Blagitko‐Dorfs

The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells

Maika Almstedt, Nadja Blagitko‐Dorfs, Jesús Duque‐Afonso et al. · Leukemia Research · 2010 · 166 citations

Hematological Malignancy, Tumor Biology, Myeloid Leukemia Cells +8

Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation

Nadja Blagitko‐Dorfs, Pascal Schlosser, Gabriele Greve et al. · Leukemia · 2018 · 108 citations

Hematological Malignancy, Hdac Inhibitors, Mixed-phenotype Acute Leukemia +11

Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy

Pragya Srivastava, Benjamin E. Paluch, Junko Matsuzaki et al. · Oncotarget · 2016 · 68 citations · Full text

Quantitative analyses of <i>DAPK1</i> methylation in AML and MDS

Rainer Claus, Björn Hackanson, Anna R. Poetsch et al. · International Journal of Cancer · 2011 · 36 citations · Full text

Engineering, Epigenetic Change, Mixed-phenotype Acute Leukemia +16

Psychophysiological insomnia and respiratory tract infections: results of an infection-diary-based cohort study

Alexandra Nieters, Nadja Blagitko‐Dorfs, Hans‐Hartmut Peter et al. · SLEEP · 2019 · 29 citations · Full text